Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanyong Jiedu Granules in Lumps-Type Non-Lactational Mastitis
NCT07512648Not yet recruiting
- Start
- Mar 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sanyong Jiedu Granules in Plasma cell mastitis (PCM) and Granulomatous lobular mastitis (GLM) (3 arms). Primary endpoint: Overall Response Rate at 8 weeks. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Sanyong Jiedu Granules
03
Conditions
Plasma cell mastitis (PCM)Granulomatous lobular mastitis (GLM)
Beyond the preview
Go deeper on NCT07512648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07512648.